Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin versus triamcinolone for frozen shoulder
IRCT20130523013442N31Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adhesive capsulitis (AC) comparing Botulinum toxin plus lidocaine with Triamcinolone plus lidocaine (2 arms). Primary endpoints: Active range of motion of shoulder, Shoulder pain and 1 more. Started Sep 2022; status: completed.
02
Drugs
botulinum toxin type Atriamcinolonelidocaine
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on IRCT20130523013442N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130523013442N31.